Bispecific antibodies that target CHI3L1 and PD-1 can effectively enhance the activity of CD8 cytotoxic T cells in the tumor microenvironment and induce the expression of the tumor suppressor gene PTEN in tumor cells, thereby playing a synergistic antitumor effect [169]. Here, CHI3L1 is linked to neoplasm.